APO Research
Talk to an analyst

APO RESEARCH · REPORT

Spatial Proteomics and Transcriptomics Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Spatial Proteomics and Transcriptomics Services Market Analysis and Forecast 2026-2032

12 August 2026192 pages

Choose your research edition.

Industry ResearchSpatial Proteomics and Transcriptomics Services Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Spatial Proteomics and Transcriptomics Services Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Spatial Proteomics and Transcriptomics Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Spatial Proteomics and Transcriptomics Services Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Spatial Proteomics and Transcriptomics Services Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Spatial Proteomics and Transcriptomics Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Spatial Proteomics and Transcriptomics Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Spatial Proteomics and Transcriptomics Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Spatial Proteomics and Transcriptomics Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Spatial Proteomics and Transcriptomics Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Spatial Proteomics and Transcriptomics Services include CellCarta, APTBIO, Vizgen, PTM BIO, Crown Bioscience, Biodesix, BGI Genomics, Shanghai OE Biotech and Westlake Omics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Spatial Proteomics and Transcriptomics Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Spatial Proteomics and Transcriptomics Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Spatial Proteomics and Transcriptomics Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Spatial Proteomics and Transcriptomics Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Spatial Proteomics and Transcriptomics Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Spatial Proteomics and Transcriptomics Services revenue, projected growth trends, production technology, application and end-user industry.

Spatial Proteomics and Transcriptomics Services Segment by Company

CellCarta

APTBIO

Vizgen

PTM BIO

Crown Bioscience

Biodesix

BGI Genomics

Shanghai OE Biotech

Westlake Omics

MRM Proteomics

Shanghai Bioprofile

Creative Proteomics

MtoZ-Biolabs

Lc-Bio Technologies

Labcorp

Precision Biomarker Laboratories (PBL)

Metware Biotechnology

Cosmos Wisdom

MS Bioworks

Quanterix

CD Genomics

Discovery Life Sciences

Syncell

Illumina

Psomagen

GENEWIZ (Azenta Life Sciences)

Novogene

Creative Bioarray

SeqMatic

Standard Biotools

Bruker Spatial Biology

BostonGene

Spatial Proteomics and Transcriptomics Services Segment by Type

Spatial Proteomics Services

Spatial Transcriptomics Services

Spatial Proteomics and Transcriptomics Services Segment by Application

Clinical Diagnostics

Drug Discovery

Others

Spatial Proteomics and Transcriptomics Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Spatial Proteomics and Transcriptomics Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Spatial Proteomics and Transcriptomics Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Spatial Proteomics and Transcriptomics Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Spatial Proteomics and Transcriptomics Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Spatial Proteomics and Transcriptomics Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Spatial Proteomics and Transcriptomics Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Spatial Proteomics and Transcriptomics Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Spatial Proteomics Services Major Player Table 3. Spatial Transcriptomics Services Major Player Table 4. Global Spatial Proteomics and Transcriptomics Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Clinical Diagnostics Major Player Table 6. Drug Discovery Major Player Table 7. Others Major Player Table 8. Spatial Proteomics and Transcriptomics Services Industry Trends Table 9. Spatial Proteomics and Transcriptomics Services Industry Drivers Table 10. Spatial Proteomics and Transcriptomics Services Industry Opportunities and Challenges Table 11. Spatial Proteomics and Transcriptomics Services Industry Restraints Table 12. Global Spatial Proteomics and Transcriptomics Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Spatial Proteomics and Transcriptomics Services Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Spatial Proteomics and Transcriptomics Services Market Share by Region (2021-2026) Table 15. Global Spatial Proteomics and Transcriptomics Services Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Spatial Proteomics and Transcriptomics Services Market Share by Region (2027-2032) Table 17. Global Spatial Proteomics and Transcriptomics Services Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Spatial Proteomics and Transcriptomics Services Revenue Market Share by Players (2021-2026) Table 19. Global Spatial Proteomics and Transcriptomics Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Spatial Proteomics and Transcriptomics Services Key Players Headquarters & Area Served Table 21. Global Spatial Proteomics and Transcriptomics Services Players, Product Type & Application Table 22. Global Spatial Proteomics and Transcriptomics Services Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Spatial Proteomics and Transcriptomics Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Spatial Proteomics and Transcriptomics Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Spatial Proteomics and Transcriptomics Services Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Spatial Proteomics and Transcriptomics Services Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Spatial Proteomics and Transcriptomics Services Revenue Market Share by Type (2021-2026) Table 29. Global Spatial Proteomics and Transcriptomics Services Revenue Market Share by Type (2027-2032) Table 30. Global Spatial Proteomics and Transcriptomics Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Spatial Proteomics and Transcriptomics Services Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Spatial Proteomics and Transcriptomics Services Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Spatial Proteomics and Transcriptomics Services Revenue Market Share by Application (2021-2026) Table 34. Global Spatial Proteomics and Transcriptomics Services Revenue Market Share by Application (2027-2032) Table 35. CellCarta Company Information Table 36. CellCarta Business Overview Table 37. CellCarta Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. CellCarta Spatial Proteomics and Transcriptomics Services Product Portfolio Table 39. CellCarta Recent Development Table 40. APTBIO Company Information Table 41. APTBIO Business Overview Table 42. APTBIO Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. APTBIO Spatial Proteomics and Transcriptomics Services Product Portfolio Table 44. APTBIO Recent Development Table 45. Vizgen Company Information Table 46. Vizgen Business Overview Table 47. Vizgen Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Vizgen Spatial Proteomics and Transcriptomics Services Product Portfolio Table 49. Vizgen Recent Development Table 50. PTM BIO Company Information Table 51. PTM BIO Business Overview Table 52. PTM BIO Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. PTM BIO Spatial Proteomics and Transcriptomics Services Product Portfolio Table 54. PTM BIO Recent Development Table 55. Crown Bioscience Company Information Table 56. Crown Bioscience Business Overview Table 57. Crown Bioscience Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Crown Bioscience Spatial Proteomics and Transcriptomics Services Product Portfolio Table 59. Crown Bioscience Recent Development Table 60. Biodesix Company Information Table 61. Biodesix Business Overview Table 62. Biodesix Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Biodesix Spatial Proteomics and Transcriptomics Services Product Portfolio Table 64. Biodesix Recent Development Table 65. BGI Genomics Company Information Table 66. BGI Genomics Business Overview Table 67. BGI Genomics Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. BGI Genomics Spatial Proteomics and Transcriptomics Services Product Portfolio Table 69. BGI Genomics Recent Development Table 70. Shanghai OE Biotech Company Information Table 71. Shanghai OE Biotech Business Overview Table 72. Shanghai OE Biotech Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Shanghai OE Biotech Spatial Proteomics and Transcriptomics Services Product Portfolio Table 74. Shanghai OE Biotech Recent Development Table 75. Westlake Omics Company Information Table 76. Westlake Omics Business Overview Table 77. Westlake Omics Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Westlake Omics Spatial Proteomics and Transcriptomics Services Product Portfolio Table 79. Westlake Omics Recent Development Table 80. MRM Proteomics Company Information Table 81. MRM Proteomics Business Overview Table 82. MRM Proteomics Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. MRM Proteomics Spatial Proteomics and Transcriptomics Services Product Portfolio Table 84. MRM Proteomics Recent Development Table 85. Shanghai Bioprofile Company Information Table 86. Shanghai Bioprofile Business Overview Table 87. Shanghai Bioprofile Spatial Proteomics and Transcriptomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Shanghai Bioprofile Spatial Proteomics and Transcriptomics Services Product Portfolio Table 89. Shanghai Bioprofile Recent Development Table 90. Creative Proteomics Company Information Table 91. Creative Proteomics Business Overview Table 92. Creative Proteomics Spatial Proteomics and Transcriptomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Creative Proteomics Spatial Proteomics and Transcriptomics Services Product Portfolio Table 94. Creative Proteomics Recent Development Table 95. MtoZ-Biolabs Company Information Table 96. MtoZ-Biolabs Business Overview Table 97. MtoZ-Biolabs Spatial Proteomics and Transcriptomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. MtoZ-Biolabs Spatial Proteomics and Transcriptomics Services Product Portfolio Table 99. MtoZ-Biolabs Recent Development Table 100. Lc-Bio Technologies Company Information Table 101. Lc-Bio Technologies Business Overview Table 102. Lc-Bio Technologies Spatial Proteomics and Transcriptomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Lc-Bio Technologies Spatial Proteomics and Transcriptomics Services Product Portfolio Table 104. Lc-Bio Technologies Recent Development Table 105. Labcorp Company Information Table 106. Labcorp Business Overview Table 107. Labcorp Spatial Proteomics and Transcriptomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Labcorp Spatial Proteomics and Transcriptomics Services Product Portfolio Table 109. Labcorp Recent Development Table 110. Precision Biomarker Laboratories (PBL) Company Information Table 111. Precision Biomarker Laboratories (PBL) Business Overview Table 112. Precision Biomarker Laboratories (PBL) Spatial Proteomics and Transcriptomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Precision Biomarker Laboratories (PBL) Spatial Proteomics and Transcriptomics Services Product Portfolio Table 114. Precision Biomarker Laboratories (PBL) Recent Development Table 115. Metware Biotechnology Company Information Table 116. Metware Biotechnology Business Overview Table 117. Metware Biotechnology Spatial Proteomics and Transcriptomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Metware Biotechnology Spatial Proteomics and Transcriptomics Services Product Portfolio Table 119. Metware Biotechnology Recent Development Table 120. Cosmos Wisdom Company Information Table 121. Cosmos Wisdom Business Overview Table 122. Cosmos Wisdom Spatial Proteomics and Transcriptomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Cosmos Wisdom Spatial Proteomics and Transcriptomics Services Product Portfolio Table 124. Cosmos Wisdom Recent Development Table 125. MS Bioworks Company Information Table 126. MS Bioworks Business Overview Table 127. MS Bioworks Spatial Proteomics and Transcriptomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. MS Bioworks Spatial Proteomics and Transcriptomics Services Product Portfolio Table 129. MS Bioworks Recent Development Table 130. Quanterix Company Information Table 131. Quanterix Business Overview Table 132. Quanterix Spatial Proteomics and Transcriptomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Quanterix Spatial Proteomics and Transcriptomics Services Product Portfolio Table 134. Quanterix Recent Development Table 135. CD Genomics Company Information Table 136. CD Genomics Business Overview Table 137. CD Genomics Spatial Proteomics and Transcriptomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. CD Genomics Spatial Proteomics and Transcriptomics Services Product Portfolio Table 139. CD Genomics Recent Development Table 140. Discovery Life Sciences Company Information Table 141. Discovery Life Sciences Business Overview Table 142. Discovery Life Sciences Spatial Proteomics and Transcriptomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. Discovery Life Sciences Spatial Proteomics and Transcriptomics Services Product Portfolio Table 144. Discovery Life Sciences Recent Development Table 145. Syncell Company Information Table 146. Syncell Business Overview Table 147. Syncell Spatial Proteomics and Transcriptomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 148. Syncell Spatial Proteomics and Transcriptomics Services Product Portfolio Table 149. Syncell Recent Development Table 150. Illumina Company Information Table 151. Illumina Business Overview Table 152. Illumina Spatial Proteomics and Transcriptomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 153. Illumina Spatial Proteomics and Transcriptomics Services Product Portfolio Table 154. Illumina Recent Development Table 155. Psomagen Company Information Table 156. Psomagen Business Overview Table 157. Psomagen Spatial Proteomics and Transcriptomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 158. Psomagen Spatial Proteomics and Transcriptomics Services Product Portfolio Table 159. Psomagen Recent Development Table 160. GENEWIZ (Azenta Life Sciences) Company Information Table 161. GENEWIZ (Azenta Life Sciences) Business Overview Table 162. GENEWIZ (Azenta Life Sciences) Spatial Proteomics and Transcriptomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 163. GENEWIZ (Azenta Life Sciences) Spatial Proteomics and Transcriptomics Services Product Portfolio Table 164. GENEWIZ (Azenta Life Sciences) Recent Development Table 165. Novogene Company Information Table 166. Novogene Business Overview Table 167. Novogene Spatial Proteomics and Transcriptomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 168. Novogene Spatial Proteomics and Transcriptomics Services Product Portfolio Table 169. Novogene Recent Development Table 170. Creative Bioarray Company Information Table 171. Creative Bioarray Business Overview Table 172. Creative Bioarray Spatial Proteomics and Transcriptomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 173. Creative Bioarray Spatial Proteomics and Transcriptomics Services Product Portfolio Table 174. Creative Bioarray Recent Development Table 175. SeqMatic Company Information Table 176. SeqMatic Business Overview Table 177. SeqMatic Spatial Proteomics and Transcriptomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 178. SeqMatic Spatial Proteomics and Transcriptomics Services Product Portfolio Table 179. SeqMatic Recent Development Table 180. Standard Biotools Company Information Table 181. Standard Biotools Business Overview Table 182. Standard Biotools Spatial Proteomics and Transcriptomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 183. Standard Biotools Spatial Proteomics and Transcriptomics Services Product Portfolio Table 184. Standard Biotools Recent Development Table 185. Bruker Spatial Biology Company Information Table 186. Bruker Spatial Biology Business Overview Table 187. Bruker Spatial Biology Spatial Proteomics and Transcriptomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 188. Bruker Spatial Biology Spatial Proteomics and Transcriptomics Services Product Portfolio Table 189. Bruker Spatial Biology Recent Development Table 190. BostonGene Company Information Table 191. BostonGene Business Overview Table 192. BostonGene Spatial Proteomics and Transcriptomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 193. BostonGene Spatial Proteomics and Transcriptomics Services Product Portfolio Table 194. BostonGene Recent Development Table 195. North America Spatial Proteomics and Transcriptomics Services Revenue by Type (2021-2026) & (US$ Million) Table 196. North America Spatial Proteomics and Transcriptomics Services Revenue by Type (2027-2032) & (US$ Million) Table 197. North America Spatial Proteomics and Transcriptomics Services Revenue by Application (2021-2026) & (US$ Million) Table 198. North America Spatial Proteomics and Transcriptomics Services Revenue by Application (2027-2032) & (US$ Million) Table 199. North America Spatial Proteomics and Transcriptomics Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 200. North America Spatial Proteomics and Transcriptomics Services Revenue by Country (2021-2026) & (US$ Million) Table 201. North America Spatial Proteomics and Transcriptomics Services Revenue by Country (US$ Million) & (2027-2032) Table 202. Europe Spatial Proteomics and Transcriptomics Services Revenue by Type (2021-2026) & (US$ Million) Table 203. Europe Spatial Proteomics and Transcriptomics Services Revenue by Type (2027-2032) & (US$ Million) Table 204. Europe Spatial Proteomics and Transcriptomics Services Revenue by Application (2021-2026) & (US$ Million) Table 205. Europe Spatial Proteomics and Transcriptomics Services Revenue by Application (2027-2032) & (US$ Million) Table 206. Europe Spatial Proteomics and Transcriptomics Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. Europe Spatial Proteomics and Transcriptomics Services Revenue by Country (2021-2026) & (US$ Million) Table 208. Europe Spatial Proteomics and Transcriptomics Services Revenue by Country (US$ Million) & (2027-2032) Table 209. China Spatial Proteomics and Transcriptomics Services Revenue by Type (2021-2026) & (US$ Million) Table 210. China Spatial Proteomics and Transcriptomics Services Revenue by Type (2027-2032) & (US$ Million) Table 211. China Spatial Proteomics and Transcriptomics Services Revenue by Application (2021-2026) & (US$ Million) Table 212. China Spatial Proteomics and Transcriptomics Services Revenue by Application (2027-2032) & (US$ Million) Table 213. Asia Spatial Proteomics and Transcriptomics Services Revenue by Type (2021-2026) & (US$ Million) Table 214. Asia Spatial Proteomics and Transcriptomics Services Revenue by Type (2027-2032) & (US$ Million) Table 215. Asia Spatial Proteomics and Transcriptomics Services Revenue by Application (2021-2026) & (US$ Million) Table 216. Asia Spatial Proteomics and Transcriptomics Services Revenue by Application (2027-2032) & (US$ Million) Table 217. Asia Spatial Proteomics and Transcriptomics Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 218. Asia Spatial Proteomics and Transcriptomics Services Revenue by Region (US$ Million) & (2021-2026) Table 219. Asia Spatial Proteomics and Transcriptomics Services Revenue by Region (US$ Million) & (2027-2032) Table 220. SAMEA Spatial Proteomics and Transcriptomics Services Revenue by Type (2021-2026) & (US$ Million) Table 221. SAMEA Spatial Proteomics and Transcriptomics Services Revenue by Type (2027-2032) & (US$ Million) Table 222. SAMEA Spatial Proteomics and Transcriptomics Services Revenue by Application (2021-2026) & (US$ Million) Table 223. SAMEA Spatial Proteomics and Transcriptomics Services Revenue by Application (2027-2032) & (US$ Million) Table 224. SAMEA Spatial Proteomics and Transcriptomics Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 225. SAMEA Spatial Proteomics and Transcriptomics Services Revenue by Country (2021-2026) & (US$ Million) Table 226. SAMEA Spatial Proteomics and Transcriptomics Services Revenue by Country (US$ Million) & (2027-2032) Table 227. Research Programs/Design for This Report Table 228. Authors List of This Report Table 229. Secondary Sources Table 230. Primary Sources List of Figures Figure 1. Spatial Proteomics and Transcriptomics Services Image Figure 2. Global Spatial Proteomics and Transcriptomics Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Spatial Proteomics and Transcriptomics Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Spatial Proteomics Services Image Figure 5. Spatial Transcriptomics Services Image Figure 6. Global Spatial Proteomics and Transcriptomics Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Spatial Proteomics and Transcriptomics Services Market Size Share 2021 VS 2025 VS 2032 Figure 8. Clinical Diagnostics Image Figure 9. Drug Discovery Image Figure 10. Others Image Figure 11. Global Spatial Proteomics and Transcriptomics Services Market Size (US$ Million) & (2021-2032) Figure 12. Global Spatial Proteomics and Transcriptomics Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Spatial Proteomics and Transcriptomics Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Spatial Proteomics and Transcriptomics Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Spatial Proteomics and Transcriptomics Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Spatial Proteomics and Transcriptomics Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Spatial Proteomics and Transcriptomics Services Revenue Market Share by Type (2021-2032) Figure 19. Global Spatial Proteomics and Transcriptomics Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Spatial Proteomics and Transcriptomics Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Spatial Proteomics and Transcriptomics Services Revenue Market Share by Application (2021-2032) Figure 22. North America Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Spatial Proteomics and Transcriptomics Services Revenue Share by Type (2021-2032) Figure 24. North America Spatial Proteomics and Transcriptomics Services Revenue Share by Application (2021-2032) Figure 25. North America Spatial Proteomics and Transcriptomics Services Revenue Share by Country (2021-2032) Figure 26. United States Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Spatial Proteomics and Transcriptomics Services Revenue Share by Type (2021-2032) Figure 31. Europe Spatial Proteomics and Transcriptomics Services Revenue Share by Application (2021-2032) Figure 32. Europe Spatial Proteomics and Transcriptomics Services Revenue Share by Country (2021-2032) Figure 33. Germany Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Spatial Proteomics and Transcriptomics Services Revenue Share by Type (2021-2032) Figure 43. China Spatial Proteomics and Transcriptomics Services Revenue Share by Application (2021-2032) Figure 44. Asia Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Spatial Proteomics and Transcriptomics Services Revenue Share by Type (2021-2032) Figure 46. Asia Spatial Proteomics and Transcriptomics Services Revenue Share by Application (2021-2032) Figure 47. Asia Spatial Proteomics and Transcriptomics Services Revenue Share by Region (2021-2032) Figure 48. Japan Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Spatial Proteomics and Transcriptomics Services Revenue Share by Type (2021-2032) Figure 56. SAMEA Spatial Proteomics and Transcriptomics Services Revenue Share by Application (2021-2032) Figure 57. SAMEA Spatial Proteomics and Transcriptomics Services Revenue Share by Country (2021-2032) Figure 58. Brazil Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Spatial Proteomics and Transcriptomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Spatial Proteomics Services
  • Spatial Transcriptomics Services
Applications
  • Clinical Diagnostics
  • Drug Discovery
  • Others
Companies covered
  • CellCarta
  • APTBIO
  • Vizgen
  • PTM BIO
  • Crown Bioscience
  • Biodesix
  • BGI Genomics
  • Shanghai OE Biotech
  • Westlake Omics
  • MRM Proteomics
  • Shanghai Bioprofile
  • Creative Proteomics
  • MtoZ-Biolabs
  • Lc-Bio Technologies
  • Labcorp
  • Precision Biomarker Laboratories (PBL)
  • Metware Biotechnology
  • Cosmos Wisdom
  • MS Bioworks
  • Quanterix
  • CD Genomics
  • Discovery Life Sciences
  • Syncell
  • Illumina
  • Psomagen
  • GENEWIZ (Azenta Life Sciences)
  • Novogene
  • Creative Bioarray
  • SeqMatic
  • Standard Biotools
  • Bruker Spatial Biology
  • BostonGene

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Spatial Proteomics and Transcriptomics Services Market by Type
  3. 1.2.1 Global Spatial Proteomics and Transcriptomics Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Spatial Proteomics Services
  5. 1.2.3 Spatial Transcriptomics Services
  6. 1.3 Spatial Proteomics and Transcriptomics Services Market by Application
  7. 1.3.1 Global Spatial Proteomics and Transcriptomics Services Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Clinical Diagnostics
  9. 1.3.3 Drug Discovery
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Spatial Proteomics and Transcriptomics Services Market Dynamics
  1. 2.1 Spatial Proteomics and Transcriptomics Services Industry Trends
  2. 2.2 Spatial Proteomics and Transcriptomics Services Industry Drivers
  3. 2.3 Spatial Proteomics and Transcriptomics Services Industry Opportunities and Challenges
  4. 2.4 Spatial Proteomics and Transcriptomics Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Spatial Proteomics and Transcriptomics Services Market Perspective (2021-2032)
  2. 3.2 Global Spatial Proteomics and Transcriptomics Services Growth Trends by Region
  3. 3.2.1 Global Spatial Proteomics and Transcriptomics Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Spatial Proteomics and Transcriptomics Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Spatial Proteomics and Transcriptomics Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Spatial Proteomics and Transcriptomics Services Revenue by Players
  2. 4.1.1 Global Spatial Proteomics and Transcriptomics Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Spatial Proteomics and Transcriptomics Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Spatial Proteomics and Transcriptomics Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Spatial Proteomics and Transcriptomics Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Spatial Proteomics and Transcriptomics Services Key Players Headquarters & Area Served
  7. 4.4 Global Spatial Proteomics and Transcriptomics Services Players, Product Type & Application
  8. 4.5 Global Spatial Proteomics and Transcriptomics Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Spatial Proteomics and Transcriptomics Services Market CR5 and HHI
  11. 4.6.3 2025 Spatial Proteomics and Transcriptomics Services Tier 1, Tier 2, and Tier 3
5 Spatial Proteomics and Transcriptomics Services Market Size by Type
  1. 5.1 Global Spatial Proteomics and Transcriptomics Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Spatial Proteomics and Transcriptomics Services Revenue by Type (2021-2032)
  3. 5.3 Global Spatial Proteomics and Transcriptomics Services Revenue Market Share by Type (2021-2032)
6 Spatial Proteomics and Transcriptomics Services Market Size by Application
  1. 6.1 Global Spatial Proteomics and Transcriptomics Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Spatial Proteomics and Transcriptomics Services Revenue by Application (2021-2032)
  3. 6.3 Global Spatial Proteomics and Transcriptomics Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 CellCarta
  2. 7.1.1 CellCarta Company Information
  3. 7.1.2 CellCarta Business Overview
  4. 7.1.3 CellCarta Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 CellCarta Spatial Proteomics and Transcriptomics Services Product Portfolio
  6. 7.1.5 CellCarta Recent Developments
  7. 7.2 APTBIO
  8. 7.2.1 APTBIO Company Information
  9. 7.2.2 APTBIO Business Overview
  10. 7.2.3 APTBIO Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 APTBIO Spatial Proteomics and Transcriptomics Services Product Portfolio
  12. 7.2.5 APTBIO Recent Developments
  13. 7.3 Vizgen
  14. 7.3.1 Vizgen Company Information
  15. 7.3.2 Vizgen Business Overview
  16. 7.3.3 Vizgen Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Vizgen Spatial Proteomics and Transcriptomics Services Product Portfolio
  18. 7.3.5 Vizgen Recent Developments
  19. 7.4 PTM BIO
  20. 7.4.1 PTM BIO Company Information
  21. 7.4.2 PTM BIO Business Overview
  22. 7.4.3 PTM BIO Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 PTM BIO Spatial Proteomics and Transcriptomics Services Product Portfolio
  24. 7.4.5 PTM BIO Recent Developments
  25. 7.5 Crown Bioscience
  26. 7.5.1 Crown Bioscience Company Information
  27. 7.5.2 Crown Bioscience Business Overview
  28. 7.5.3 Crown Bioscience Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Crown Bioscience Spatial Proteomics and Transcriptomics Services Product Portfolio
  30. 7.5.5 Crown Bioscience Recent Developments
  31. 7.6 Biodesix
  32. 7.6.1 Biodesix Company Information
  33. 7.6.2 Biodesix Business Overview
  34. 7.6.3 Biodesix Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Biodesix Spatial Proteomics and Transcriptomics Services Product Portfolio
  36. 7.6.5 Biodesix Recent Developments
  37. 7.7 BGI Genomics
  38. 7.7.1 BGI Genomics Company Information
  39. 7.7.2 BGI Genomics Business Overview
  40. 7.7.3 BGI Genomics Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 BGI Genomics Spatial Proteomics and Transcriptomics Services Product Portfolio
  42. 7.7.5 BGI Genomics Recent Developments
  43. 7.8 Shanghai OE Biotech
  44. 7.8.1 Shanghai OE Biotech Company Information
  45. 7.8.2 Shanghai OE Biotech Business Overview
  46. 7.8.3 Shanghai OE Biotech Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Shanghai OE Biotech Spatial Proteomics and Transcriptomics Services Product Portfolio
  48. 7.8.5 Shanghai OE Biotech Recent Developments
  49. 7.9 Westlake Omics
  50. 7.9.1 Westlake Omics Company Information
  51. 7.9.2 Westlake Omics Business Overview
  52. 7.9.3 Westlake Omics Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Westlake Omics Spatial Proteomics and Transcriptomics Services Product Portfolio
  54. 7.9.5 Westlake Omics Recent Developments
  55. 7.10 MRM Proteomics
  56. 7.10.1 MRM Proteomics Company Information
  57. 7.10.2 MRM Proteomics Business Overview
  58. 7.10.3 MRM Proteomics Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 MRM Proteomics Spatial Proteomics and Transcriptomics Services Product Portfolio
  60. 7.10.5 MRM Proteomics Recent Developments
  61. 7.11 Shanghai Bioprofile
  62. 7.11.1 Shanghai Bioprofile Company Information
  63. 7.11.2 Shanghai Bioprofile Business Overview
  64. 7.11.3 Shanghai Bioprofile Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Shanghai Bioprofile Spatial Proteomics and Transcriptomics Services Product Portfolio
  66. 7.11.5 Shanghai Bioprofile Recent Developments
  67. 7.12 Creative Proteomics
  68. 7.12.1 Creative Proteomics Company Information
  69. 7.12.2 Creative Proteomics Business Overview
  70. 7.12.3 Creative Proteomics Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Creative Proteomics Spatial Proteomics and Transcriptomics Services Product Portfolio
  72. 7.12.5 Creative Proteomics Recent Developments
  73. 7.13 MtoZ-Biolabs
  74. 7.13.1 MtoZ-Biolabs Company Information
  75. 7.13.2 MtoZ-Biolabs Business Overview
  76. 7.13.3 MtoZ-Biolabs Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  77. 7.13.4 MtoZ-Biolabs Spatial Proteomics and Transcriptomics Services Product Portfolio
  78. 7.13.5 MtoZ-Biolabs Recent Developments
  79. 7.14 Lc-Bio Technologies
  80. 7.14.1 Lc-Bio Technologies Company Information
  81. 7.14.2 Lc-Bio Technologies Business Overview
  82. 7.14.3 Lc-Bio Technologies Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Lc-Bio Technologies Spatial Proteomics and Transcriptomics Services Product Portfolio
  84. 7.14.5 Lc-Bio Technologies Recent Developments
  85. 7.15 Labcorp
  86. 7.15.1 Labcorp Company Information
  87. 7.15.2 Labcorp Business Overview
  88. 7.15.3 Labcorp Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Labcorp Spatial Proteomics and Transcriptomics Services Product Portfolio
  90. 7.15.5 Labcorp Recent Developments
  91. 7.16 Precision Biomarker Laboratories (PBL)
  92. 7.16.1 Precision Biomarker Laboratories (PBL) Company Information
  93. 7.16.2 Precision Biomarker Laboratories (PBL) Business Overview
  94. 7.16.3 Precision Biomarker Laboratories (PBL) Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Precision Biomarker Laboratories (PBL) Spatial Proteomics and Transcriptomics Services Product Portfolio
  96. 7.16.5 Precision Biomarker Laboratories (PBL) Recent Developments
  97. 7.17 Metware Biotechnology
  98. 7.17.1 Metware Biotechnology Company Information
  99. 7.17.2 Metware Biotechnology Business Overview
  100. 7.17.3 Metware Biotechnology Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Metware Biotechnology Spatial Proteomics and Transcriptomics Services Product Portfolio
  102. 7.17.5 Metware Biotechnology Recent Developments
  103. 7.18 Cosmos Wisdom
  104. 7.18.1 Cosmos Wisdom Company Information
  105. 7.18.2 Cosmos Wisdom Business Overview
  106. 7.18.3 Cosmos Wisdom Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Cosmos Wisdom Spatial Proteomics and Transcriptomics Services Product Portfolio
  108. 7.18.5 Cosmos Wisdom Recent Developments
  109. 7.19 MS Bioworks
  110. 7.19.1 MS Bioworks Company Information
  111. 7.19.2 MS Bioworks Business Overview
  112. 7.19.3 MS Bioworks Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  113. 7.19.4 MS Bioworks Spatial Proteomics and Transcriptomics Services Product Portfolio
  114. 7.19.5 MS Bioworks Recent Developments
  115. 7.20 Quanterix
  116. 7.20.1 Quanterix Company Information
  117. 7.20.2 Quanterix Business Overview
  118. 7.20.3 Quanterix Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Quanterix Spatial Proteomics and Transcriptomics Services Product Portfolio
  120. 7.20.5 Quanterix Recent Developments
  121. 7.21 CD Genomics
  122. 7.21.1 CD Genomics Company Information
  123. 7.21.2 CD Genomics Business Overview
  124. 7.21.3 CD Genomics Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  125. 7.21.4 CD Genomics Spatial Proteomics and Transcriptomics Services Product Portfolio
  126. 7.21.5 CD Genomics Recent Developments
  127. 7.22 Discovery Life Sciences
  128. 7.22.1 Discovery Life Sciences Company Information
  129. 7.22.2 Discovery Life Sciences Business Overview
  130. 7.22.3 Discovery Life Sciences Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  131. 7.22.4 Discovery Life Sciences Spatial Proteomics and Transcriptomics Services Product Portfolio
  132. 7.22.5 Discovery Life Sciences Recent Developments
  133. 7.23 Syncell
  134. 7.23.1 Syncell Company Information
  135. 7.23.2 Syncell Business Overview
  136. 7.23.3 Syncell Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  137. 7.23.4 Syncell Spatial Proteomics and Transcriptomics Services Product Portfolio
  138. 7.23.5 Syncell Recent Developments
  139. 7.24 Illumina
  140. 7.24.1 Illumina Company Information
  141. 7.24.2 Illumina Business Overview
  142. 7.24.3 Illumina Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  143. 7.24.4 Illumina Spatial Proteomics and Transcriptomics Services Product Portfolio
  144. 7.24.5 Illumina Recent Developments
  145. 7.25 Psomagen
  146. 7.25.1 Psomagen Company Information
  147. 7.25.2 Psomagen Business Overview
  148. 7.25.3 Psomagen Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  149. 7.25.4 Psomagen Spatial Proteomics and Transcriptomics Services Product Portfolio
  150. 7.25.5 Psomagen Recent Developments
  151. 7.26 GENEWIZ (Azenta Life Sciences)
  152. 7.26.1 GENEWIZ (Azenta Life Sciences) Company Information
  153. 7.26.2 GENEWIZ (Azenta Life Sciences) Business Overview
  154. 7.26.3 GENEWIZ (Azenta Life Sciences) Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  155. 7.26.4 GENEWIZ (Azenta Life Sciences) Spatial Proteomics and Transcriptomics Services Product Portfolio
  156. 7.26.5 GENEWIZ (Azenta Life Sciences) Recent Developments
  157. 7.27 Novogene
  158. 7.27.1 Novogene Company Information
  159. 7.27.2 Novogene Business Overview
  160. 7.27.3 Novogene Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  161. 7.27.4 Novogene Spatial Proteomics and Transcriptomics Services Product Portfolio
  162. 7.27.5 Novogene Recent Developments
  163. 7.28 Creative Bioarray
  164. 7.28.1 Creative Bioarray Company Information
  165. 7.28.2 Creative Bioarray Business Overview
  166. 7.28.3 Creative Bioarray Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  167. 7.28.4 Creative Bioarray Spatial Proteomics and Transcriptomics Services Product Portfolio
  168. 7.28.5 Creative Bioarray Recent Developments
  169. 7.29 SeqMatic
  170. 7.29.1 SeqMatic Company Information
  171. 7.29.2 SeqMatic Business Overview
  172. 7.29.3 SeqMatic Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  173. 7.29.4 SeqMatic Spatial Proteomics and Transcriptomics Services Product Portfolio
  174. 7.29.5 SeqMatic Recent Developments
  175. 7.30 Standard Biotools
  176. 7.30.1 Standard Biotools Company Information
  177. 7.30.2 Standard Biotools Business Overview
  178. 7.30.3 Standard Biotools Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  179. 7.30.4 Standard Biotools Spatial Proteomics and Transcriptomics Services Product Portfolio
  180. 7.30.5 Standard Biotools Recent Developments
  181. 7.31 Bruker Spatial Biology
  182. 7.31.1 Bruker Spatial Biology Company Information
  183. 7.31.2 Bruker Spatial Biology Business Overview
  184. 7.31.3 Bruker Spatial Biology Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  185. 7.31.4 Bruker Spatial Biology Spatial Proteomics and Transcriptomics Services Product Portfolio
  186. 7.31.5 Bruker Spatial Biology Recent Developments
  187. 7.32 BostonGene
  188. 7.32.1 BostonGene Company Information
  189. 7.32.2 BostonGene Business Overview
  190. 7.32.3 BostonGene Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  191. 7.32.4 BostonGene Spatial Proteomics and Transcriptomics Services Product Portfolio
  192. 7.32.5 BostonGene Recent Developments
8 North America
  1. 8.1 North America Spatial Proteomics and Transcriptomics Services Revenue (2021-2032)
  2. 8.2 North America Spatial Proteomics and Transcriptomics Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Spatial Proteomics and Transcriptomics Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Spatial Proteomics and Transcriptomics Services Revenue by Type (2027-2032)
  5. 8.3 North America Spatial Proteomics and Transcriptomics Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Spatial Proteomics and Transcriptomics Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Spatial Proteomics and Transcriptomics Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Spatial Proteomics and Transcriptomics Services Revenue by Application (2027-2032)
  9. 8.5 North America Spatial Proteomics and Transcriptomics Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Spatial Proteomics and Transcriptomics Services Revenue by Country
  11. 8.6.1 North America Spatial Proteomics and Transcriptomics Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Spatial Proteomics and Transcriptomics Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Spatial Proteomics and Transcriptomics Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Spatial Proteomics and Transcriptomics Services Revenue (2021-2032)
  2. 9.2 Europe Spatial Proteomics and Transcriptomics Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Spatial Proteomics and Transcriptomics Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Spatial Proteomics and Transcriptomics Services Revenue by Type (2027-2032)
  5. 9.3 Europe Spatial Proteomics and Transcriptomics Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Spatial Proteomics and Transcriptomics Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Spatial Proteomics and Transcriptomics Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Spatial Proteomics and Transcriptomics Services Revenue by Application (2027-2032)
  9. 9.5 Europe Spatial Proteomics and Transcriptomics Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Spatial Proteomics and Transcriptomics Services Revenue by Country
  11. 9.6.1 Europe Spatial Proteomics and Transcriptomics Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Spatial Proteomics and Transcriptomics Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Spatial Proteomics and Transcriptomics Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Spatial Proteomics and Transcriptomics Services Revenue (2021-2032)
  2. 10.2 China Spatial Proteomics and Transcriptomics Services Revenue by Type (2021-2032)
  3. 10.2.1 China Spatial Proteomics and Transcriptomics Services Revenue by Type (2021-2026)
  4. 10.2.2 China Spatial Proteomics and Transcriptomics Services Revenue by Type (2027-2032)
  5. 10.3 China Spatial Proteomics and Transcriptomics Services Revenue Share by Type (2021-2032)
  6. 10.4 China Spatial Proteomics and Transcriptomics Services Revenue by Application (2021-2032)
  7. 10.4.1 China Spatial Proteomics and Transcriptomics Services Revenue by Application (2021-2026)
  8. 10.4.2 China Spatial Proteomics and Transcriptomics Services Revenue by Application (2027-2032)
  9. 10.5 China Spatial Proteomics and Transcriptomics Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Spatial Proteomics and Transcriptomics Services Revenue (2021-2032)
  2. 11.2 Asia Spatial Proteomics and Transcriptomics Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Spatial Proteomics and Transcriptomics Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Spatial Proteomics and Transcriptomics Services Revenue by Type (2027-2032)
  5. 11.3 Asia Spatial Proteomics and Transcriptomics Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Spatial Proteomics and Transcriptomics Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Spatial Proteomics and Transcriptomics Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Spatial Proteomics and Transcriptomics Services Revenue by Application (2027-2032)
  9. 11.5 Asia Spatial Proteomics and Transcriptomics Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Spatial Proteomics and Transcriptomics Services Revenue by Country
  11. 11.6.1 Asia Spatial Proteomics and Transcriptomics Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Spatial Proteomics and Transcriptomics Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Spatial Proteomics and Transcriptomics Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Spatial Proteomics and Transcriptomics Services Revenue (2021-2032)
  2. 12.2 SAMEA Spatial Proteomics and Transcriptomics Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Spatial Proteomics and Transcriptomics Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Spatial Proteomics and Transcriptomics Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Spatial Proteomics and Transcriptomics Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Spatial Proteomics and Transcriptomics Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Spatial Proteomics and Transcriptomics Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Spatial Proteomics and Transcriptomics Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Spatial Proteomics and Transcriptomics Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Spatial Proteomics and Transcriptomics Services Revenue by Country
  11. 12.6.1 SAMEA Spatial Proteomics and Transcriptomics Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Spatial Proteomics and Transcriptomics Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Spatial Proteomics and Transcriptomics Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst